Blueprint Medicines Corporation
Blueprint Medicines Corporation (BPMC) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · BPMC · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
74
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Blueprint Medicines Corporation insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
BPMC insider buying and selling by quarter
BPMC insider selling · BPMC insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · BPMC ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
BPMC executive sell shares · BPMC board member insider trading · BPMC insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jul 17, 2025 | Landsittel Michael CFO | Award | 21,353 | — | Form 4 |
| Jul 17, 2025 | Landsittel Michael CFO | Other | 51,102 | — | Form 4 |
| Jul 17, 2025 | Landsittel Michael CFO | Other | 43,175 | — | Form 4 |
| Jul 17, 2025 | Dable Habib J Director | Other | 3,902 | — | Form 4 |
| Jul 17, 2025 | Dable Habib J Director | Other | 8,742 | — | Form 4 |
| Jul 17, 2025 | Hurley Ariel PAO | Award | 2,460 | — | Form 4 |
| Jul 17, 2025 | Hurley Ariel PAO | Other | 16,146 | — | Form 4 |
| Jul 17, 2025 | Hurley Ariel PAO | Other | 3,378 | — | Form 4 |
| Jul 17, 2025 | Tsai John Director | Other | 3,902 | — | Form 4 |
| Jul 17, 2025 | Tsai John Director | Other | 8,742 | — | Form 4 |
| Jul 17, 2025 | COATS LONNEL Director | Other | 6,144 | — | Form 4 |
| Jul 17, 2025 | Hewes L. Becker Chief Medical Officer | Award | 21,353 | — | Form 4 |
| Jul 17, 2025 | Hewes L. Becker Chief Medical Officer | Other | 50,165 | — | Form 4 |
| Jul 17, 2025 | Hewes L. Becker Chief Medical Officer | Other | 1,607 | — | Form 4 |
| Jul 17, 2025 | Seely Lynn Director | Other | 3,902 | — | Form 4 |
| Jul 17, 2025 | Seely Lynn Director | Other | 13,254 | — | Form 4 |
| Jul 17, 2025 | Carter Percy H. Chief Scientific Officer | Award | 21,353 | — | Form 4 |
| Jul 17, 2025 | Carter Percy H. Chief Scientific Officer | Other | 56,614 | — | Form 4 |
| Jul 17, 2025 | Carter Percy H. Chief Scientific Officer | Other | 17,894 | — | Form 4 |
| Jul 17, 2025 | Rossi Christina COO | Award | 39,456 | — | Form 4 |
| Jul 17, 2025 | Rossi Christina COO | Other | 82,374 | — | Form 4 |
| Jul 17, 2025 | Rossi Christina COO | Other | 20,628 | — | Form 4 |
| Jul 17, 2025 | Haviland Kate CEO · Director | Award | 129,210 | — | Form 4 |
| Jul 17, 2025 | Haviland Kate CEO · Director | Other | 224,410 | — | Form 4 |
| Jul 17, 2025 | Haviland Kate CEO · Director | Other | 70,729 | — | Form 4 |
Carter Percy H.
Chief Scientific Officer
Date
Jul 17
Shares
21,353
Price
—
Value
—
Carter Percy H.
Chief Scientific Officer
Date
Jul 17
Shares
56,614
Price
—
Value
—
Carter Percy H.
Chief Scientific Officer
Date
Jul 17
Shares
17,894
Price
—
Value
—
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About BPMC insider trading
BPMC insider trades
Blueprint Medicines Corporation (BPMC) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Landsittel Michael (CFO), Hurley Ariel (PAO), Hewes L. Becker (Chief Medical Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. BPMC insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Blueprint Medicines Corporation's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
BPMC insider trading · 5 questionsThe insiders of Blueprint Medicines Corporation (BPMC) include executives and directors such as Landsittel Michael (CFO), Hurley Ariel (PAO), Hewes L. Becker (Chief Medical Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026